COVID-19 vaccines and treatments portal (2024)

Nuvaxovid XBB.1.5 (SARS-CoV-2 recombinant spike protein) Novavax Inc Vaccine Authorized 2023-12-05No 124 COMIRNATY Omicron XBB.1.5 (raxtozinameran) Pfizer Canada ULC Vaccine Authorized 2023-09-28No 123 SPIKEVAX XBB.1.5 (andusomeran) Moderna Biopharma Canada Corporation Vaccine Authorized 2023-09-12No 122 SPIKEVAX Bivalent Original / Omicron BA.4/5 (elasomeran/ davesomeran) Cancelled by sponsor January 19th, 2024 Moderna Biopharma Canada Corporation Vaccine Authorized 2022-11-03No 117 COMIRNATY ORIGINAL/OMICRON BA.1 (tozinameran and riltozinameran) BioNTech Manufacturing GmbH Vaccine Authorized 2022-10-21No 116 ACTEMRA (tocilizumab) Hoffmann-La Roche Limited Treatment Authorized 2022-10-13No 115 COMIRNATY Original & Omicron BA.4/BA.5 (tozinameran / famtozinameran) BioNTech Manufacturing GmbH Vaccine Authorized 2022-10-07No 114 SPIKEVAX Bivalent (elasomeran/ imelasomeran) Cancelled by sponsor January 19th, 2024 Moderna Biopharma Canada Corporation Vaccine Authorized 2022-09-01No 111 EVUSHELD (cilgavimab / tixagevimab) AstraZeneca Canada Inc. Treatment Authorized 2022-04-14No 109 Covifenz (virus-like particles (VLP) of SARS-CoV-2 spike protein) Cancelled by sponsor March 31st, 2023 Medicago Inc Vaccine Authorized 2022-02-24No 106 NUVAXOVID (SARS-CoV-2 recombinant spike protein) Cancelled by sponsor February 29th, 2024 Novavax Inc Vaccine Authorized 2022-02-17No 104 PAXLOVID (nirmatrelvir / ritonavir) Pfizer Canada ULC Treatment Authorized 2022-01-17No 102 Sotrovimab (sotrovimab) GlaxoSmithKline Inc Treatment Authorized By Interim Order 2021-07-30No 36 Casirivimab and imdevimab (casirivimab / imdevimab) Hoffmann-La Roche Limited Treatment Authorized By Interim Order 2021-06-09No 34 JCOVDEN (Ad26.COV2.S [recombinant]) Cancelled by sponsor July 26th, 2023. Previously Janssen COVID-19 Vaccine. Janssen Inc Vaccine Authorized By Interim Order 2021-03-05No 27 COVISHIELD (ChAdOx1-S [recombinant]) Expired September 16 2021 Verity Pharmaceuticals Inc/Serum Institute of India (in partnership with AstraZeneca Canada Inc) Vaccine Authorized By Interim Order 2021-02-26No 29 Vaxzevria (ChAdOx1-S [recombinant]) Cancelled by sponsor December 19th, 2023. Previously Astrazeneca Covid-19 Vaccine. AstraZeneca Canada Inc. Vaccine Authorized By Interim Order 2021-02-26No 28 SPIKEVAX (elasomeran) Cancelled by sponsor January 19th, 2024. Previously COVID-19 Vaccine Moderna. Moderna Biopharma Canada Corporation Vaccine Authorized 2020-12-23No 15 Comirnaty (tozinameran) previously Pfizer-BioNTech COVID-19 Vaccine BioNTech Manufacturing GmbH Vaccine Authorized By Interim Order 2020-12-09No 16 Bamlanivimab (bamlanivimab) Eli Lilly Canada Inc Treatment Authorized By Interim Order 2020-11-20No 8 Veklury (remdesivir) Gilead Sciences Canada Inc Treatment Authorized 2020-07-27No 9 Nitric oxide (nitric oxide) Sanotize Research & Development Corp. Treatment Under review Under review Yes 76 COVID-19 Vaccine Moderna – Application for Pediatric Use (ages 12-17) (mRNA-1273 SARS-CoV-2) ModernaTX, Inc. Vaccine Under review Under review No 55 Regdanvimab (regdanvimab) Celltrion HealthCare Co Ltd Treatment Under review Under review No 53 Olumiant (baricitinib) Eli Lilly Canada Inc Treatment Under review Under review Yes 39 Coronavirus-like Particle (CoVLP) COVID-19 Vaccine (coronavirus-like particle [CoVLP]) Medicago Inc Vaccine Under review Under review No 38 Leronlimab (leronlimab) CytoDyn, Inc. Treatment Under review Under review No 35 Bamlanivimab and etesevimab (LY-CoV555 / LY-CoV016) Eli Lilly Canada Inc Treatment Under review Under review No 32 Novavax COVID-19 Vaccine (NVX-CoV2373) Novavax Inc Vaccine Under review Under review No 31 Favipiravir (favipiravir) Dr Reddys Laboratories Ltd Treatment Under review Under review 17